IL6 and neoplasm: Therefore, our study initially showed that hCAFs have an immunosuppressive effect upon DCs, and provided us with a novel mechanism that involves tumor immune escape and a novel cancer immunotherapeutic approach (for example, by targeting CAFs, IDO or IL-6).